|
CBFA2T2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.32229999999711E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.979600E-04 |
| Normal-vs-Stage2 |
4.561900E-02 |
| Normal-vs-Stage3 |
1.970830E-01 |
| Normal-vs-Stage4 |
3.779000E-01 |
| Stage1-vs-Stage2 |
6.075400E-01 |
| Stage1-vs-Stage3 |
6.010000E-01 |
| Stage1-vs-Stage4 |
3.483000E-03 |
| Stage2-vs-Stage3 |
4.580600E-01 |
| Stage2-vs-Stage4 |
2.492400E-02 |
| Stage3-vs-Stage4 |
1.045990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.92589999997917E-06 |
| Normal-vs-AfricanAmerican |
2.816300E-02 |
| Normal-vs-Asian |
8.840600E-01 |
| Caucasian-vs-AfricanAmerican |
1.791760E-01 |
| Caucasian-vs-Asian |
2.659200E-01 |
| AfricanAmerican-vs-Asian |
3.701600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.569900E-04 |
| Normal-vs-Female |
1.6415599999986E-05 |
| Male-vs-Female |
2.306300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.418400E-02 |
| Normal-vs-Extreme_Weight |
4.408300E-02 |
| Normal-vs-Obese |
1.880480E-03 |
| Normal-vs-Extreme_Obese |
1.074840E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.921000E-01 |
| Normal_Weight-vs-Obese |
6.522400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.294600E-01 |
| Extreme_Weight-vs-Obese |
1.978230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.267000E-01 |
| Obese-vs-Extreme_Obese |
9.548000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.933800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.14189999994774E-06 |
| Normal-vs-Age(61-80Yrs) |
2.716300E-03 |
| Normal-vs-Age(81-100Yrs) |
9.790400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.062400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.723800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.610850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.000300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.062500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.474000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.27740000022136E-07 |
| Normal-VS-Type2 PRCC |
8.502400E-01 |
| Normal-VS-KIRP CIMP |
7.698800E-01 |
| Normal-VS-Unclassified PRCC |
8.004300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.87259999998124E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.577300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.001800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.394000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.443100E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.017000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.117200E-01 |
| Normal-vs-N1 |
1.277010E-01 |
| Normal-vs-N2 |
1.809640E-01 |
| N0-vs-N1 |
5.169600E-01 |
| N0-vs-N2 |
2.918400E-03 |
| N1-vs-N2 |
7.703500E-03 |
|
|
